Next-Generation Sequencing Is Revolutionizing Precision Medicine
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read MorePosted by Andy Lundin | Mar 3, 2023 | Lab Automation, Molecular Diagnostics |
Automated NGS platforms can help determine if a patient is fit for a targeted therapy, enabling more effective precision medicine.
Read MorePosted by Andy Lundin | Jan 24, 2023 | Lung Cancer |
Thermo Fisher Scientific is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic test for Tagrisso.
Read MorePosted by Andy Lundin | Jan 11, 2023 | Dementias & Alzheimer’s |
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read MorePosted by Andy Lundin | Dec 30, 2022 | Leukemia |
Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.
Read MorePosted by Chris Wolski | Dec 26, 2022 | Microscopy, Tissue Processing |
The method leverages AI to improve the quality of images opening the possibility for real-time diagnoses during surgery.
Read More